Vincent Ippolito
Vermögen: 117 345 $ am 31.10.2026
Vermögen: 117 345 $ am 31.10.2026
Vincent Peter Ippolito is Executive Chairman & President at Botanix Pharmaceuticals Ltd. and Botanix Pharmaceuticals, Inc. since 2019.
Mr. Ippolito is Director at Suneva Medical, Inc. since 2017.
Former roles include Chief Commercial Officer, EVP-Sales & Marketing at Medicis Pharmaceutical Corp.
from 2003 to 2014; Vice President-Sales at Novartis AG in 2003; Chief Commercial Officer & Executive VP at Anacor Pharmaceuticals LLC from 2014 to 2017; Senior Vice President & General Manager-Aesthetics at Bausch Health Cos., Inc.; and President & Chief Operating Officer at Dermavant Sciences, Inc. from 2017 to 2019.
Education includes undergraduate studies at the University of Wisconsin-Eau Claire.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 16 668 311 ( 0,6 % ) | 117 345 $ | 31.10.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BOTANIX PHARMACEUTICALS LIMITED | Vorsitzender | 18.07.2019 |
Botanix Pharmaceuticals, Inc.
Botanix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of musculoskeletal diseases, such as oacne, psoriasis and atopic dermatitis | Vorsitzender | 01.07.2019 |
Suneva Medical, Inc.
Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and commercializes novel, differentiated aesthetic products | Direktor/Vorstandsmitglied | 28.08.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Operates as a a biotechnology company focused on dermatology | Präsident | 01.01.2019 |
| ANACOR PHARMACEUTICALS INC | Corporate Officer/Principal | 30.09.2017 |
| MEDICIS PHARMACEUTICAL CORP | Vertrieb & Marketing | 01.03.2014 |
| NOVARTIS AG | Vertrieb & Marketing | 02.01.2003 |
| BAUSCH HEALTH COMPANIES INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Medicis Pharmaceutical Corp.
Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for dermatological usages | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Botanix Pharmaceuticals Ltd.
Botanix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dermatology and antimicrobial products | Health Technology |
Anacor Pharmaceuticals LLC
Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
Bausch Health Cos., Inc.
Bausch Health Cos., Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Suneva Medical, Inc.
Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and commercializes novel, differentiated aesthetic products | Electronic Technology |
University of Wisconsin-Eau Claire
University of Wisconsin-Eau Claire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Botanix Pharmaceuticals, Inc.
Botanix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of musculoskeletal diseases, such as oacne, psoriasis and atopic dermatitis | Health Technology |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Operates as a a biotechnology company focused on dermatology | Health Technology |
Bitte wählen Sie Ihre Edition
Alle länderspezifischen Finanzinformationen